anti-STEAP1 CAR T-cell therapy (Fred Hutchinson Cancer Research Center/ PromiCell Therapeutics)

N/A

Report date: 2025/06/11 10:32:18

Base Information

Drug Nameanti-STEAP1 CAR T-cell therapy (Fred Hutchinson Cancer Research Center/ PromiCell Therapeutics)
Drug Alias NameSTEAP1-targeting CAR T-cellsSTEAP1 CAR-T Cellsanti-STEAP1 CAR T-cell therapy (Fred Hutchinson Cancer Research Center/ PromiCell Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocytes stimulantsSix-transmembrane epithelial antigen of the prostate 1modulatorsImmunostimulants
TargetsSix-transmembrane epithelial antigen of the prostate 1
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsProstatic NeoplasmsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesPromiCell Therapeutics IncFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate NeoplasmsProstatic NeoplasmsAdenocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A